Furthermore, we determined the correlation of METTL2A expression with clinical parameters of patients with breast cancer and analyzed related signaling pathways and potential therapeutic agents of METTL2A in BRCA patients. The gene discussed is METTL2A; the disease is invasive breast carcinoma.